BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Pharm Country

  Janssen Research & Development Release: STELARA™ Awarded 2012 International Prix Galien

  October 5, 2012

   · 

  7 min read
• Deals

  Fosun Pharma’s Hong Kong IPO Set to Raise $600 Million

  October 5, 2012

   · 

  1 min read
• Drug Development

  Drug Relieves Major Depression in Hours Instead of Weeks, Yale University Study Reveals

  October 5, 2012

   · 

  1 min read
• BioMidwest

  EnteroMedics Lands $45 Million Financing

  October 5, 2012

   · 

  4 min read
• BioMidwest

  Tactile Systems Technology Raises $10.4 Million

  October 5, 2012

   · 

  3 min read
• National Institute for Clinical Excellence (NICE) U-turns on Novartis AG’s Lucentis for Diabetic Macular Oedema

  October 5, 2012

   · 

  1 min read
• Drug Development

  Sanofi (France) Flags Positive Study on Lantus Insulin

  October 5, 2012

   · 

  1 min read
• Drug Development

  XenoPort, Inc. Reports Favorable Metabolism and Pharmacokinetics of XP23829, a Novel Fumaric Acid Ester, in Phase 1 Trial

  October 5, 2012

   · 

  1 min read
• Business

  Aastrom Biosciences, Inc. CEO Tim M. Mayleben Announces Plan to Retire

  October 5, 2012

   · 

  4 min read
• Pharm Country

  Collegium Pharmaceutical, Inc. Announces Poster Presentation for Oxycodone DETERx® , a Tamper-Resistant, Extended-Release Opioid at 6th Annual Pain Therapeutics Summit

  October 5, 2012

   · 

  1 min read